Frazier Life Sciences Public Fund, L.P. 13D and 13G filings for Maze Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-10 10:55 am Purchase |
2025-02-03 | 13G | Maze Therapeutics, Inc. MAZE |
Frazier Life Sciences Public Fund, L.P. | 3,193,900 7.300% |
3,193,900 (New Position) |
Filing |